Gastroduodenal mucosal lesions and coronary atherosclerosis severity in patients with coronary artery disease;Oštećenje gastroduodenalne sluznice itežina koronarne ateroskleroze u bolesnika s koronarnom bolešću srca

Lijecnicki Vjesnik

Volumn 130, Issue 9-10, 2008, Pages 228-233

  Banić, Marko ^a   Fabijanić, Damir ^b   Kardum, Duško ^a   Anić, Branimir ^c   Sutlić, Željko ^a   Romić, Željko ^a   Petričušić, Lidija ^a   Bonacin, Damir ^d   Kujundžić, Milan ^a  

^a University of Zagreb   (Croatia)

^b KBC a Split

^c UNIVERSITY OF ZAGREB   (Croatia)

^d Interna Klinika

Author keywords

Coronary artery disease radiography, complications; Duodenum pathology; Gastric mucosa pathology; Intestinal mucosa pathology; Peptic ulcer complications

Indexed keywords

ANTIULCER AGENT;

ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIGESTIVE TRACT ENDOSCOPY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PEPTIC ULCER;

ANTI-ULCER AGENTS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER;

EID: 56749163924     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sternby NH. Atherosclerosis and peptic ulcer. Bull WHO 1976;53:571-7.
2. Canino V, Massa F, Bonardi L. Morphological studies of gastric arteries in patients with gastro-duodenal ulcer. Arch Sci Med (Torino) 1976;133:109-13.
3. Rasso AM, Rispoli P, Sisto G, Castagno PL. Direct surgery of lesions of the femoropopliteal tract. Indications and treatment. Minerva Cardioangiol 1998;36:295.
4. Banić M, Sutlić Z, Biočina B i sur. Peptic ulcer disease in dyspeptic patients with ischemic heart disease: search and treat? Z Gastroenterol 2005;43:581-6
5. Fabijanić D, Banić M, Sutlić Ž i sur. Gastroduodenal lesions in coronary artery disease patients: frequency, endoscopic characteristics and risk factors. S Med J 2007;28:447-9.
6. Sapoznikov B, Vilkin A, Hershkovici M, Fishman M, Eliakim R, Niv Y. Minidose aspirin and gastrointestinal bleeding - a retrospective, case-control study in hospitalized patients. Dig Dis Sci 2005;50:1621-4.
7. Niv Y, Battler A, Abuksis G, Gal E, Sapoznikov B, Vilkin A. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci 2005;50:78-80.
8. Kinjo K, Sato H, Sato H i sur. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 2002;66:805-10.
9. Kanabay M, Gur G, Yucel M, Yilmaz U, Muderrisoglu H. Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig Dis Sci 2005;50:2071-4.
10. Wang JY, Liu SB, Chen SY, Dobson A. Risk factors for peptic ulcer in Shanghai. Int J Epidemiol 1996;25:638-43.
11. Korman MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 1983;85:871-4.
12. Eastwood GL. Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol 1997;25 (Suppl. 1):1-7.
13. Gorunovsiaia IG. Features of ulcer disease in elderly patients with ischemic heart disease. Eksp Klin Gastroenterol 2002;117:16-21.
14. Loginov AS, Zvenigorodskaia LA, Potapova VB, Arbuzova VG, Korzhikov VV, Nilova TV. The characteristics of peptic ulcer in subjects with concomitant ischemic heart disease. Ter Arkh. 1998;70:9-13.
15. Baena Diez J, Lopez Gosp D, De La Poza AM, Raido Quintana E, Vila Capdevila M, Martinez Martinez J. Association between ischemic heart disease and peptic ulcer. A case-control study. Gastroenterol Hepatol 2001;24:421-6.
16. Korzihov VV, Zvenigorodskaia LA, Arbuzova VC. The characteristics of the clinical picture and course of gastric and duodenal peptic ulcer in patients with ischemic heart disease. Ter Arkh 1990;62:50-2.
17. Chemin VV, Bazhenov DV, Osadechii VA. Clinico-morphological features of acute gastroduodenal erosion and ulcers in an unstable course of myocardial ischemia and role in disturbances of microcirculation, stomach function and their development. Ter Arkh 2003;75:14-8.
18. Bi LC, Kaunitz JD. Gastroduodenal mucosal defense: an integrated protective response. Curr Opinn Gastroenterol 2003;19:526-532.
19. Gensini GG. A more meaningful scoring system for determing the severity of coronary heart disease. Am J Cardiol 1983;51:606.
20. Lanza FL, Royer GL, Nelson RS, Chen TT, Sechman CE, Rack MF. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 1981;75:17-21.
21. Louw JA, Marks IN. Peptic ulcer disease. Curr Opin Gastroenterol 2004;20:533-7.
22. Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal and rectal prostaglandin levels and on mucosal injury. Gastroenterology 1999;117:17-25.
23. Feldman M, Shewmake K, Cryer B. Time course inhibition of gastric and platelet COX activity vs acetilsalicylic acid in humans. Am J Physiol Gastrointest Liver Physiol 2000;272:G113-G120.
24. Taha AS, Hundal O, Hawkwy CJ. Famotidine for the prevention of gastric and duodenal ulcer caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996;34:1435-9.
25. Yeomans ND, Tullasay Z, Juhasz L. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflamatory drugs. N Engl J Med 1998;338:719-26.
26. Chan FKL, Chung SCS, Suen BY i sur. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
27. Hawkey CJ, Tuillasay Z, Szczepanski L. Helicobacter pylori eradication in patients taking non-steroidal anti-inflammatory drugs: the HELP NSAIDs study. Lancet 1998;352:1016-21.